Programmed Death-1 (PD-1) has received considerable attention as a key regulator of CD8 + T cell exhaustion during chronic infection and cancer because blockade of this pathway partially reverses T cell dysfunction. Although the PD-1 pathway is critical in regulating established "exhausted" CD8 + T cells (T EX cells), it is unclear whether PD-1 directly causes T cell exhaustion. We show that PD-1 is not required for the induction of exhaustion in mice with chronic lymphocytic choriomeningitis virus (LCMV) infection. In fact, some aspects of exhaustion are more severe with genetic deletion of PD-1 from the onset of infection. Increased proliferation between days 8 and 14 postinfection is associated with subsequent decreased CD8 + T cell survival and disruption of a critical proliferative hierarchy necessary to maintain exhausted populations long term. Ultimately, the absence of PD-1 leads to the accumulation of more cytotoxic, but terminally differentiated, CD8 + T EX cells. These results demonstrate that CD8 + T cell exhaustion can occur in the absence of PD-1. They also highlight a novel role for PD-1 in preserving T EX cell populations from overstimulation, excessive proliferation, and terminal differentiation.
Chronic viral infections, such as HIV, HCV, and others, place a significant strain on antiviral T cell responses, forcing continued prolifera tion, cytokine production, and killing of in fected cells for months or years (Virgin et al., 2009; Wherry, 2011) . As a result, antiviral CD8 + T cell functions become suboptimal over time, a phenomenon known as T cell exhaustion (Gallimore et al., 1998; Zajac et al., 1998) . Two cardinal features of exhausted CD8 + T cells (T EX cells) are the gradual loss of effector capa bilities and the sustained high expression of multiple inhibitory receptors (Wherry, 2011) . CD8 + T EX cells also have altered expression of key transcription factors, including Tbet, Eome sodermin (Eomes), FoxO1, and others Kao et al., 2011; Paley et al., 2012; Staron et al., 2014; Martinez et al., 2015) . Importantly, CD8 + T cell exhaustion contributes to failed immune control during chronic infection and cancer (Wherry, 2011; Pardoll, 2012) .
The inhibitory receptor Programmed Death1 (PD1) is a central regulator of CD8 + T cell exhaustion. PD1 is thought to mediate its inhibitory effects via the local and transient intracellular attenuation of positive signals from TCR/CD3 and costimulatory receptors. Upon ligation, both the ITIM and ITSM within the cytoplasmic domain of PD1 are phosphorylated, leading to the recruitment of tyrosine phospha tases such as SHP2 (Okazaki et al., 2001; Parry et al., 2005; Riley, 2009) . SHP2 can then de phosphorylate signaling molecules downstream of TCR/CD3 and CD28, including CD3, Zap70, and PKC (Parry et al., 2005; Riley, 2009; Yokosuka et al., 2012) . PD1 also inhibits both the PI3K-Akt-mTOR and Ras-MEK-ERK prevent the development of exhaustion. In fact, PD1 KO virusspecific CD8 + T cells were less functional and had higher expression of other inhibitory receptors compared with WT virusspecific CD8 + T cells. Early overstimulation and robust proliferation in the absence of PD1 led to disruption of a critical proliferative hierarchy between Tbet hi and Eomes hi subsets of CD8 + T EX cells that is necessary for sustained re sponses during chronic infections (Paley et al., 2012) . As a re sult, longterm proliferation and stability of T EX cell responses was compromised without PD1. However, improved cyto toxic ability and increased localization of T EX cells to periph eral tissues without PD1 suggests that the PD1 pathway has previously unappreciated roles in shaping CD8 + T EX cell pop ulations. These findings demonstrate that PD1 signals do not instruct the development of CD8 + T cell exhaustion. How ever, PD1 is required to prevent terminal differentiation of CD8 + T EX cells while simultaneously controlling important anatomical and functional aspects of these cells. These findings have important implications for understanding the longterm impact of PD1-based therapies in humans.
RESULTS

Co-adoptive transfer strategy allows for examination of PD-1-deficient virus-specific CD8 + T cells during chronic LCMV infection
Direct infection of PD1 or PDL1 KO mice with LCMV clone 13 causes lethal immunopathology (Barber et al., 2006; Frebel et al., 2012) . Previous experiments using adoptive transfer of LCMVspecific TCRtransgenic CD8 + T cells (P14 cells) also resulted in immunopathology when 10 4 PD1 KO P14 cells were transferred (Frebel et al., 2012) . We hy pothesized that using lower numbers of P14 cells would avoid immunemediated damage, allowing for analysis of PD1 KO P14 cell exhaustion during chronic infection. Thus, a coadoptive transfer strategy was used in which equal num bers of WT and PD1 KO P14 cells were transferred into congenically distinct WT mice, followed by infection with LCMV clone 13 ( Fig. 1 A) . This strategy allowed for direct comparison of WT and PD1 KO P14 cell responses in the same recipient mice during chronic viral infection while con trolling for precursor frequency, TCR repertoire, viral load, inflammatory environment, and immunopathology. To de termine whether this coadoptive transfer strategy mitigated alterations in viral load and/or morbidity that occur as a result of transfer of high numbers of P14 cells (Blattman et al., 2009; Frebel et al., 2012) , viremia and pathogenesis were assessed in mice that received varying numbers of WT and PD1 KO P14 cells. Transfer of >1,000 total P14 cells (500 WT + 500 PD1 KO) resulted in reduced viral load (Fig. 1 B) and sig nificant morbidity (Fig. 1 C) compared with no P14 transfer, consistent with previous studies (Blattman et al., 2009; Frebel et al., 2012) . However, transfer of 500 total P14 cells (250 WT + 250 PD1 KO) did not significantly alter viremia or morbidity during chronic LCMV infection compared with mice that did not receive P14 cells (Fig. 1, B and C). One concern is that the presence of a monoclonal P14 T cell population pathways, impacting glucose metabolism and cell cycle regu lation (Parry et al., 2005; Patsoukis et al., 2012) . Expression of PD1 and its primary ligand PDL1 is highly upregulated during chronic infection and cancer. The importance of this elevated PD1 and PDL1 expression has been demonstrated in several animal models where in vivo antibodymediated blockade of the PD1 pathway reinvigorates CD8 + T EX cell responses and decreases viral load or tumor burden (Blank et al., 2004; Iwai et al., 2005; Barber et al., 2006; Velu et al., 2009) . Recent studies have extended these observations from animal models to humans, demonstrating a potent ability of PD1 pathway blockade to revitalize antiviral immune re sponses (Day et al., 2006; Petrovas et al., 2006; Urbani et al., 2006; Boni et al., 2007) , as well as antitumor immunity in latestage cancer patients (Brahmer et al., 2012; Topalian et al., 2012) . The observations of reversibility of exhaustion by the PD1 pathway blockade indicate that CD8 + T EX cells, or at least a subset of the population, are not terminally dysfunc tional (Blackburn et al., 2008) . Furthermore, blockade of other inhibitory receptors alone and in combination with PD1-PDL1 blockade suggests that PD1 is the major inhibitory receptor controlling exhaustion Kassu et al., 2010; Sakuishi et al., 2010; Wherry, 2011) . Although it is clear that PD1-based therapies have exciting clinical po tential and can dramatically improve immune responses, the precise role of PD1 in CD8 + T EX cells remains incom pletely understood.
A fundamental unresolved question is what role PD1 signals play in initiating and/or establishing the program of T cell exhaustion. One possibility is that PD1 directly causes the development of CD8 + T cell exhaustion. This question has previously been challenging to address because PD1 pathway deficiency results in excessive CD8 + T cell-mediated immunopathology and altered viral pathogenesis, preventing analysis of T cell responses after the first week postinfection (p.i.; Barber et al., 2006; Frebel et al., 2012) . However, the robust functionality of CD8 + T cells in the absence of PD1 at these early time points suggests that T cell exhaustion may not develop without PD1 signals. This outcome would im plicate the PD1 pathway as a major regulatory network in ducing the development of T cell exhaustion. Alternatively, PD1 could inhibit CD8 + T cell function during chronic in fection but may not play a direct role as the initiator of the program of exhaustion. In this scenario, CD8 + T cells could still become exhausted even in settings of PD1 deficiency. The implications of these two distinct possibilities are impor tant for the design and implementation of therapies blocking or manipulating the PD1 pathway in cancer, infections, and other diseases.
Here we have used a dual adoptive transfer approach that allowed us to study the development of PD1-deficient (PD1 KO) antiviral CD8 + T cell responses during chronic lympho cytic choriomeningitis virus (LCMV) infection in the absence of lethal immunemediated damage and altered viral patho genesis. Using this approach, we found that genetic deletion of PD1 on virusspecific CD8 + T cells was insufficient to PD-1-deficient CD8 + T cells proliferate robustly during the acute phase of infection but develop early signs of dysfunction We next tested whether signs of exhaustion in the absence of PD1 could be detected early during chronic infection. To interrogate this issue, the phenotype and function of WT and might drive epitope escape (Pircher et al., 1989; Blattman et al., 2009 ). However, under the conditions used here, virus derived from recipients of WT and PD1 KO P14 cells was capable of inducing a robust GP33specific CD8 + T cell re sponse when inoculated into new naive mice, indicating an intact GP33 sequence even in the presence of PD1 KO P14 cells (Fig. 1, D and E ). These results demonstrate that a co adoptive transfer approach with small numbers of WT and PD1 KO P14 cells can be used to address the development of CD8 + T cell exhaustion in the absence of cellintrinsic PD1 signals.
CD8 + T cell exhaustion develops in the absence of PD-1
Previous studies demonstrating potent inhibition of CD8 + T cells by the PD1 pathway suggest that PD1 may be es sential for the development of T cell exhaustion (Barber et al., 2006; Keir et al., 2008; Wherry, 2011; Frebel et al., 2012) . Thus, we tested the hypothesis that PD1 KO P14 cells would not become exhausted during chronic LCMV infec tion. First, we examined the ability of WT versus PD1 KO P14 cells to produce cytokines at day 42 p.i. after ex vivo peptide restimulation. At this time point, WT P14 cells dis played characteristic features of exhaustion. Compared with control memory P14 cells generated after acute LCMV infec tion, exhausted WT P14 cells less efficiently produced IFN (mean of 86% vs. 51%) or coproduced IFN and TNF (mean of 76% vs. 8%; Fig. 2 A) . Surprisingly, production of IFN was even more severely reduced in the PD1 KO P14 popu lation, with a mean of only 39% of cells producing IFN (Fig. 2, A and B) . PD1 KO P14 cells also developed a sig nificant reduction in IFN production per cell, as indicated by lower mean fluorescence intensity (MFI) of IFN expres sion compared with WT P14 cells in the same mice ( Fig. 2 A and not depicted). In addition, PD1 KO P14 cells exhibited reduced polyfunctionality compared with WT P14 cells, with minimal coproduction of IFN and TNF (Fig. 2, A and C) . There was a similar trend toward decreased total numbers of PD1 KO IFN + TNF + cells compared with WT in the spleen (Fig. 2 C) . In contrast, the ability to degranulate, as measured by LAMP1/CD107a staining, was retained (not depicted). Reduced cytokine production in the absence of PD1 also corresponded with higher expression of multiple other inhibitory receptors, a second key feature of exhaus tion. PD1 KO P14 cells expressed higher Lag3, 2B4/CD244, CD160, and Tigit than WT P14 cells at day 42 p.i. (Fig. 2 D) . A higher frequency of PD1 KO P14 cells also simultane ously coexpressed Lag3, 2B4, Tim3, and CD160 compared with WT cells (Fig. 2 E) . Analysis of WT and PD1 KO P14 cells in separate mice resulted in similar findings, confirm ing the CD8 + T cell-intrinsic nature of this effect ( Fig. 2 F and not depicted). These findings indicate that CD8 + T cell exhaustion can develop in the absence of PD1. In fact, two defining features of CD8 + T EX cells, loss of cytokine poly functionality, and elevated inhibitory receptor coexpression, were more severe when CD8 + T cell-intrinsic PD1 signals were absent. there was still a significant increase in the total number of PD1 KO IFNproducing cells compared with WT ( Fig. 3 B, right). PD1 KO P14 cells also had elevated expression (Fig. 3 C) and coexpression (Fig. 3 D) of several other inhibitory recep tors at this time point. Collectively, these data suggest that dysfunction of PD1 KO P14 cells may begin early during LCMV clone 13 infection. However, the increase in total num bers of PD1 KO P14 cells suggests that loss of PD1 signals might improve the activation and proliferation of virusspecific CD8 + T cells, despite inducing slight defects in cytokine pro duction and elevated inhibitory receptor expression.
To test whether the absence of PD1 resulted in acceler ated or more robust initial activation of CD8 + T cells, we examined the early activation and proliferation of WT and PD1 KO P14 cells were analyzed at the peak of the effector response, day 8 p.i. Both WT and PD1 KO P14 cells were highly capable of producing IFN at this time point (Fig. 3 A) , consistent with previous work (Parry et al., 2005; Butte et al., 2007; Patsoukis et al., 2012; Yokosuka et al., 2012; Zinselmeyer et al., 2013) . However, PD1 KO P14 cells displayed a sub tle, but significant, reduction in production of IFN and co production of IFN and TNF ( Fig. 3 A and not depicted). PD1 KO P14 cells also greatly outnumbered WT P14 cells in the spleen, blood, and other organs at day 8 p.i. (Fig. 3 B, left; and not depicted), consistent with the notion that PD1 signals restrain CD8 + T cell responses. Therefore, despite the decrease in percell functionality indicated by a reduced fre quency of IFN + cells within the PD1 KO P14 population, proliferation of WT versus PD1 KO P14 cells when co cultured with GP33 peptide-pulsed splenocytes in vitro (Fig. 3 E, right) . At day 8 p.i. in the spleen, nearly 100% of both WT and PD1 KO P14 cells expressed the proliferation marker Ki67, suggesting considerable cell division by both WT and PD1 KO P14 cells over the preceding 2-4 d (Fig. 3 F) . To PD1 KO P14 cells in the mixed chimera model. PD1 KO P14 cells had a trend toward a proliferative advantage from days 2 to 3 p.i. in the spleen compared with WT P14 cells using CellTrace Violet (CTV) dilution to track early cell di vision, but there was no difference in proliferation by day 4 p.i. (Fig. 3 E, left) . There was also no difference in the early Values indicate MFI for phospho-proteins for individual mice (left) and multiple mice (right). All error bars indicate ±SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (paired Student's t test) for all graphs (A-H). All data are representative of two to five independent experiments with five to eight mice per group.
Decreased survival of CD8 + T cells after the effector phase in the absence of PD-1
We next examined how the absence of PD1 affected the transition to later stages of infection. After peak expansion, PD1 KO P14 cells underwent significantly greater contrac tion between days 15 and 42 p.i. (88% decrease) compared with WT P14 cells (75% decrease; Fig. 4 A) . We hypothe sized that this more dramatic contraction was caused by de creased survival in the absence of inhibitory signals from the PD1 pathway. To test this possibility, WT and PD1 KO P14 cells were assessed for markers of cell death between days 14 and 20 p.i. in the spleen. A higher frequency of PD1 KO P14 cells stained with LIVE/DEAD Aqua (Fig. 4 B) and An nexin V (Fig. 4 C) , markers of compromised cell membrane integrity which are associated with apoptosis and cell death. PD1 KO P14 cells also displayed increased staining with fluor escent caspase substrates (FLICA) at day 15 p.i. (Fig. 4 D) . In addition, ex vivo survival of PD1 KO P14 cells was decreased, as demonstrated by a significant reduction in the total frequency of live cells remaining after a 10h in vitro culture (not de picted). Thus, in the absence of PD1, virusspecific CD8 + T cells experience considerably more cell death than WT CD8 + T cells of the same specificity in the same inflammatory environment. These findings suggest that PD1 prevents over stimulation of CD8 + T cells and subsequent excessive cell death during chronic viral infection.
Decreased proliferation and long-term durability of PD-1 KO T EX cells
The increase in cell death of PD1 KO P14 cells suggests that longterm durability of virusspecific CD8 + T cells may obtain a more precise assessment of proliferation at the later stages of effector expansion, we next used a brief BrdU pulse to examine proliferation between days 7 and 8 p.i. During this time, PD1 KO P14 cells proliferated significantly more than WT P14 cells (Fig. 3 G) . Collectively, these findings suggest that PD1 restricts virusspecific CD8 + T cell responses during chronic infection by restraining proliferation during the ef fector phase.
We hypothesized that the robust proliferation of PD1 KO P14 cells at day 8 p.i. was caused by increased TCR signaling in vivo in the absence of PD1-mediated inhibi tion. Previous studies have demonstrated that loss of PD1 signals in vitro leads to increased phosphorylation of both proximal and distal signaling molecules downstream of the TCR and costimulatory receptors (Okazaki et al., 2001; Parry et al., 2005; Yokosuka et al., 2012) . Indeed, at this ef fector stage PD1 KO P14 cells had augmented TCR re sponsiveness, as demonstrated by increased phosphorylation of Akt 473 and ERK 202/204 (not depicted), as well as mTOR 2448 and S6 235/236 (Fig. 3 H) . Despite this robust TCR stimula tion and proliferation, WT and PD1 KO P14 cells had similar expression of activation and differentiation markers, such as CD69, KLRG1, CD27, CD44, and CD25, during early activation (days 1-4 p.i.) and during the effector phase (day 8 p.i.; not depicted). Thus, PD1 controls virus specific CD8 + T cell proliferation early during chronic in fection by tempering TCR signals at the peak of infection. These data also suggest that tempering of TCR responsive ness and proliferation during the effector phase may have a benefit in preserving T cell function into the chronic phase of infection. P14 cell responses stabilized in frequency and absolute num ber after day 48 p.i. in CD4 + T cell-depleted mice (Fig. 5 B  and not depicted) . In contrast, the number of PD1 KO P14 cells failed to stabilize and gradually declined over time. By day 300 p.i., the total number of PD1 KO P14 cells was less than that of WT P14 cells (Fig. 5 B) . This deterioration in the number of PD1 KO P14 cells was also indicated by a significant decrease in the total numbers of IFN + TNF + cells in the spleen at this time point (Fig. 5 C, left) . The in ability of PD1 KO P14 cells to form a stable, longterm population of T EX cells in the spleen could be caused, at least in part, by the increased cell death observed in this population. However, ongoing antigendriven proliferation is central to the durability of T EX cell populations (McCune et al., 2000; Shin et al., 2007) . To interrogate how ongoing proliferation is impacted by PD1 deficiency, we examined proliferation of WT and PD1 KO P14 cells over the time course of LCMV clone 13 infection. Despite similar expression be compromised in the absence of PD1. During LCMV clone 13 infection, the frequency and absolute number of WT P14 cells began to stabilize in the spleen and blood be tween days 22 and 42 p.i. (Fig. 5 A and not depicted) , con sistent with previous findings (Shin et al., 2007; Wherry et al., 2007; Blattman et al., 2009 ). In contrast, PD1 KO P14 cells declined in both frequency and absolute number until at least day 42 p.i., suggesting that longterm durability of virusspecific CD8 + T cell responses may be compromised in the absence of PD1 (Fig. 5 A) . However, viremia during LCMV clone 13 infection of C57BL/6 mice gradually re solves by days 60-90 p.i, complicating the interpretation of changes in exhaustion at late time points (Matloubian et al., 1994; Blackburn et al., 2009 ). Therefore, we next used a model of chronic LCMV infection where transient depletion of CD4 + T cells before infection with LCMV clone 13 leads to persistent, lifelong viremia (Matloubian et al., 1994) . As observed in CD4 + T cell-sufficient clone 13 infection, WT cell population (Fig. 6 E) . In addition, PD1 KO P14 cells had increased Eomes expression on a percell basis at days 15 (Fig. 6 A) and 42 p.i. (Fig. 6 B) .
We next asked whether this change in Tbet and Eomes expression observed in exhausted PD1 KO P14 cells truly represented a shift in subset dynamics to Eomes hi progeny. To test this idea, PD1 KO P14 cells were assessed for other cardinal features of Eomes hi cells (Paley et al., 2012) . PD1 KO P14 cells, like WT Eomes hi T EX cells, were significantly increased in peripheral tissues, including the bone marrow and liver (Fig. 6 F) . Key functional properties of Eomes hi cells were also observed in PD1 KO P14 cells. Despite decreased cytokine production (Fig. 2 , A-C) and proliferation (Fig. 5 , D and E), PD1 KO P14 cells displayed enhanced cytotoxicity compared with WT P14 cells (Fig. 6 G) , as well as increased ex pression of Granzyme B at day 42 p.i. (Fig. 6 H) . These differ ences were also consistent with higher expression of multiple inhibitory receptors observed on PD1 KO P14 cells, as well as the patterns of coinhibitory receptor expression on the Eomes hi subset of WT P14 T EX cells (Fig. 2 , D and E; Paley et al., 2012) . Thus, PD1 KO P14 cells accumulate mainly as terminally dif ferentiated Eomes hi progeny. These findings suggest that PD1 controls proliferation dynamics during chronic viral infection, at least in part, by preventing loss of Tbet hi progenitor cells. In ad dition to changes in proliferation, loss of PD1 signals leads to a T EX cell pool with more extensive tissue distribution and en hanced cytotoxicity, which may be an important consideration when using PD1 blockade for chronic infections and cancer.
DISCUSSION
Expression of the inhibitory receptor PD1 is strongly associ ated with CD8 + T cell exhaustion in chronic infection and cancer (Wherry, 2011; Pardoll, 2012) . The ability to partially restore T cell functions by PD1-PDL1 pathway blockade suggests a fundamental link between this pathway and the development of CD8 + T cell exhaustion (Barber et al., 2006; Wherry, 2011) . However, a key unanswered question is whether PD1 directly causes or induces T cell exhaustion. Here, we investigated this question using approaches that control for confounding issues, such as changes in pathogen esis or viral load, in the absence of PD1. We found that ge netic absence of PD1 on antigenspecific CD8 + T cells did not prevent exhaustion during chronic LCMV infection. Consistent with the negative regulatory role of this pathway, CD8 + T cell stimulation and proliferation were greatly en hanced by the absence of PD1 during the acute phase of infection. However, PD1 deficiency also led to increased apoptosis during the contraction phase. Moreover, perma nent absence of PD1 resulted in the dysregulation of a key proliferative hierarchy required to sustain CD8 + T EX cells during chronic infection (Paley et al., 2012) . Without PD1, CD8 + T EX cells accumulated as Eomes hi cells, whereas the Tbet hi progenitor pool was depleted. In addition, this shift was accompanied by functional changes associated with an altered balance of these subsets. Cytokine production and proliferation declined in the absence of PD1 as the result of of Ki67 during the acute phase of infection, PD1 KO P14 cells had decreased Ki67 expression beginning at day 27 p.i. in the blood (Fig. 5 D) . By day 42 p.i., PD1 KO P14 cells had dramatically reduced expression of Ki67 in the spleen of both CD4 + T cell-sufficient (clone 13) and CD4 + T celldepleted (Cl13 CD4) mice (Fig. 5 E) , and this defect in ongoing proliferation persisted until at least day 300 p.i. in CD4depleted mice (Fig. 5 C, right) (Fig. 5 F) . Of note, by day 35 p.i., both WT and PD1 KO P14 cells had minimal phosphory lation of S6 235/236 and other signaling molecules (not de picted). Thus, the PD1 KO P14 cells that survive into the chronic phase of infection are a less durable population and have reduced TCR responsiveness, as well as limited prolif erative ability.
PD-1 controls CD8 + T EX cell proliferative dynamics by regulating Tbet hi and Eomes hi subsets
Recent work has demonstrated that two subsets of CD8 + T EX cells, Tbet hi progenitors and Eomes hi progeny, exist in a proliferative hierarchy to sustain longterm CD8 + T cell re sponses during chronic viral infections (Paley et al., 2012) . Based on these observations, we next investigated whether loss of PD1 impacted the balance between these two subsets and whether changes in these subsets could account for the altered TCR responsiveness, proliferation, and stability of the PD1 KO P14 population. To test this idea, we assessed expression of Tbet and Eomes at days 8, 15, and 42 p.i. in WT and PD1 KO P14 cells. At day 8 p.i., increased expres sion of both Tbet and Eomes was observed in PD1 KO P14 cells, which is consistent with the increased activation of these cells early in infection (Fig. 6 A) . However, on day 15 p.i., PD1 KO P14 cells had a significant decrease in Tbet expression (Fig. 6 A) , which was followed by a substantial reduction in Tbet MFI on day 42 p.i. (Fig. 6 B) . Reduced Tbet expression on a percell basis in PD1 KO P14 cells was accompanied by a significant decline in the frequency and total number of Tbet hi progenitor cells compared with WT P14 cells (Fig. 6, C-E) . As a result, the PD1 KO P14 cell population was skewed toward the Eomes hi subset, as demonstrated by an increase in the frequency of Eomes hi cells (Fig. 6, C and D) . There was also a trend toward in creased total numbers of Eomes hi cells in the PD1 KO P14 indicate that this pathway also plays a critical role in protect ing CD8 + T EX cells from excessive stimulation, terminal ex haustion, and erosion of the population over time. These findings have implications for prolonged clinical treatments with PD1 pathway antagonists where the benefit of rejuve nating CD8 + T EX cells may have to be balanced with the risk of overstimulation and lack of longterm stability. loss of the slightly more functional Tbet hi population, but cy totoxicity was improved because the Eomes hi subset that pos sesses better killing capacity was enriched. These findings reveal an unexpected dual role for PD1 signals during chronic viral infection. Although PD1 clearly negatively regulates CD8 + T cell responses during the chronic phase of infection (Barber et al., 2006; Wherry, 2011) , these new observations . All error bars indicate ±SEM. *, P < 0.05; **, P < 0.01 (paired Student's t test for A-F and H and unpaired Student's t test for G) for all graphs (A-H). All data are representative of two to five independent experiments with at least five mice per group.
These Eomes hi progeny are more terminally differentiated and lack future proliferative capacity (Paley et al., 2012) . It has recently been shown that the transcription factor FoxO1 regulates the transition between Tbet hi and Eomes hi T EX cells by integrating changes in signals from the P13K-Akt-mTOR pathway. Increased FoxO1 expression leads to upregulation of PD1 and conversion into Eomes hi cells (Staron et al., 2014) . Our current data indicate a critical, but perhaps some what paradoxical, role for PD1 in this proliferative hierar chy. Without PD1, CD8 + T EX cells accumulate as Eomes hi terminally differentiated progeny. These data support the idea that PD1 tempers the continual activation and differen tiation of the Tbet hi progenitor pool and partially protects this subset from chronic overstimulation. Thus, in the steadystate, PD1-mediated inhibition of Tbet hi T EX cell stimulation may preserve these cells for future activation and generation of terminal progeny. How this PD1-mediated effect is linked to FoxO1, TCR responsiveness, or other metabolic path ways in the T EX cell subsets remains to be determined. The ability to exploit this proliferative reserve by transiently re moving PD1 signals (e.g., via blockade) has resulted in major new clinical opportunities to treat chronic infections and cancer (Barber et al., 2006; Brahmer et al., 2012; Topalian et al., 2012) . It will be important in the future to determine how transient versus permanent loss of PD1 signaling on responding T cells affects T EX cell subset stability and line age dynamics.
Previous work has also demonstrated that Tbet directly represses expression of the Pdcd1 gene (encoding PD1; Kao et al., 2011) . In addition, persisting antigen stimulation can lead to loss of Tbet expression (Kao et al., 2011; Paley et al., 2012) . Collectively, these observations suggest a model whereby intermediate levels of PD1 expression inhibit TCR signaling during chronic infection to help maintain Tbet expression, as well as to promote Tbet hi cell survival. Tbet, in turn, partially represses Pdcd1 transcription and maintains PD1 expression at an intermediate level (Kao et al., 2011) , which may pre serve cytokine production and proliferative potential in the Tbet hi T EX cell subset. Interestingly, FoxO1deficient CD8 + T cells that fail to maintain PD1 expression also cannot be sustained during chronic LCMV infection (Staron et al., 2014) , further supporting a connection between PD1 and durability of CD8 + T EX cells. Thus, the model proposed here indicates a critical feedback loop centered on PD1 in T EX cell subset maintenance and conversion. Our data suggest a novel dual role for PD1 signals in negatively regulating CD8 + T cell proliferation and function during chronic infection, but also in sustaining Tbet hi progenitor cells, a population critical for a proliferative hierarchy which partially controls chronic infection.
Despite the clear clinical promise and many early suc cesses of PD1 or PDL1 blockade, the optimal therapeutic strategy for targeting the PD1 pathway remains to be deter mined. Transient blockade of PD1-PDL1 can have pro found effects on the reinvigoration of CD8 + T EX cells during chronic infections and cancer, as well as reduced viral or Although complete genetic absence of PD1 is unlikely to manifest clinically, several important genetic variants in and around the PDCD1 gene have been described that are associated with autoimmunity, cancer prognosis, or chronic viral infection ( James et al., 2005; VelázquezCruz et al., 2007; Muenst et al., 2010 Muenst et al., , 2013 Zhang et al., 2012) . Al though mechanistically it remains unclear how most of these genetic variants affect the expression or function of PD1, these observations do suggest that genetic variation in the PD1 pathway could be an important parameter affecting the development of T cell responses and PD1 checkpoint block ade in humans. It will be interesting to determine whether there are any relationships between these human PDCD1 polymorphisms and changes in the development and/or dynamics of CD8 + T EX cells we have observed in mice. In addition to natural genetic variation, it is now possible to genetically engineer T cells for adoptive immunotherapeutic approaches (Restifo et al., 2012; Grupp et al., 2013) . PD1 might be an interesting target to consider in such therapeuti cally modified T cell adoptive immunotherapy approaches. However, our data suggest that such approaches to modify or genetically ablate PD1 should be considered with caution.
One interesting aspect of the PD1-deficient CD8 + T cell response that develops during chronic LCMV infection is the elevated expression of many other inhibitory receptors. In the absence of PD1, we observed higher expression of Lag3, 2B4/CD244, CD160, and Tigit. Most, if not all, of these in hibitory receptors are upregulated after TCR signaling in acutely activated T cells, and their elevated expression may provide a mechanism to temper increased TCR stimulation in the absence of PD1-mediated inhibition, particularly during the chronic phase of infection. In addition, the upregulation of other inhibitory receptors in the absence of PD1 signals could partially explain the synergy observed during coblockade of PD1 and other inhibitory receptors Wherry, 2011; Pardoll, 2012) and reveal opportunities for targeting other inhibitory receptors in conjunction with PD1. Thus, these observations support use of coblockade of multiple inhibitory receptors in cancer patients for optimal reversal of T cell exhaustion. This issue will be interesting to examine clinically as the timing and/or sequence with which different inhibitory receptor blockades are introduced may in fluence the therapeutic outcome.
Our data provide a cellular mechanism to explain the populationbased effects of PD1 deficiency during chronic infection. PD1 is critical for regulation of a proliferative hi erarchy necessary to maintain CD8 + T EX cell populations. We have previously described a lineage relationship within the CD8 + T EX cell pool where Tbet hi PD1 int cells give rise to Eomes hi PD1 hi cells (Paley et al., 2012) . Importantly, Tbet hi and Eomes hi T EX cell subsets are found not only in chronic LCMV infection of mice, but also in human HCV and HIV infections (Paley et al., 2012; Buggert et al., 2014) . The transition between subsets is driven by persisting antigen and is accompanied by extensive division, downregulation of Tbet, and upregulation of Eomes (Paley et al., 2012) . and "stress" on the CD8 + T cell compartment is high and constant, absence of a key negative regulatory pathway may result in T cell overstimulation. In settings where antigen lev els have been controlled to a low level, continued loss of PD1 signals may be less detrimental to the stability to the T cell population and may promote CD8 + T cell functional ity. Future studies will be necessary to investigate these possi ble outcomes.
In summary, we have identified a novel role for the PD1 pathway in regulating CD8 + T cell exhaustion during chronic viral infection. PD1 signals are critical for preventing the early overactivation and proliferation of CD8 + T cells in re sponse to chronic infection, thus promoting the establish ment and stability of exhausted T cell responses. Additional work will be necessary to further define the molecular path ways regulated by PD1 in CD8 + T EX cells and to compare genetic loss of PD1 with the more clinically relevant setting of PD1 pathway blockade.
MATERIALS AND METHODS
Mice and infections. PD1-deficient (PD1 KO) mice were crossed to C57BL/6 P14 mice (Pircher et al., 1989) to generate PD1 KO P14 mice. Mice were infected with 4 × 10 6 PFU of LCMV clone 13 strain by i.v. injection to generate a chronic infection. In experiments with CD4 depletion, 200 µg antiCD4 antibody (GK1.5; Bio X Cell) was admin istered i.p. on days 1 and 1 of LCMV infection. Viral titers were measured as previously described (Kao et al., 2011) . All animals were housed at the University of Pennsylvania (Philadelphia, PA). Experiments were performed in accordance with protocols approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Adoptive transfer and lymphocyte isolation. CD8 + T cells were iso lated from peripheral blood or spleens of naive WT or PD1 KO P14 mice. For spleen isolation, P14 cells were purified by CD8 negative selection (STEMCELL Technologies). The indicated number of WT or PD1 KO cells was transferred into separate naive recipient mice or mixed at a 1:1 ratio and transferred into naive recipient mice. For proliferation assays, P14 cells were labeled with 10 mM CTV (Life Technologies) before transfer.
Flow cytometry, cell sorting, and phospho-flow. All cells were stained with LIVE/DEAD Fixable Dead Cell Stain (Life Technologies) to discrimi nate live from dead cells. Surface staining was performed as described previ ously (Kao et al., 2011) . For intracellular cytokine staining, singlecell suspensions were incubated for 5 h at 37°C in the presence of GolgiPlug (BD) and GolgiStop (BD) with or without 1 µM GP33 peptide. Cells were then stained with a Cytofix/Cytoperm kit (BD) according to the manufac turer's instructions. For intracellular staining of transcription factors, a FoxP3 staining kit (eBioscience) was used according to the manufacturer's instruc tion. For signaling experiments, cells were rested for 1-2 h at 37°C in 10% RPMI, followed by restimulation with 1 µM GP33 peptide for 60 min. Phosphorylated Akt 473 (pAkt 473 ), pS6 235/236 , pERK 202/204 , and pmTOR 2448 were detected using paraformaldehyde fixation and methanol permeabiliza tion. Antibodies used for flow cytometry were purchased from BD (CD4, CD8, CD19, CD44, 2B4, Ki67, pERK 202/204 , and pmTOR 2448 ), BioLegend (PD1 [RMP130 clone], Tim3, TNF, IFN, and Tbet), R&D Systems (MIP1), eBioscience (CD8, Lag3, CD160, 2B4, CD45.1, CD45.2, CD107, and Eomes), or Cell Signaling Technology (pAkt 473 and pS6 235/236 ). MHC class I peptide tetramers were made and used as described previously (Wherry et al., 2003b; Kao et al., 2011) . Polycaspase analysis was performed with Flica Vybrant FAM Poly Caspases Assay kit (Life Technologies). Data were collected on an LSRII (BD) and analyzed with FlowJo software (Tree Star). Cell sorting was performed using a FACSAria II (BD).
tumor burden (Wherry, 2011; Pardoll, 2012) . However, we found that permanent absence of PD1 from the onset of in fection did not prevent the development of exhaustion. In fact, CD8 + T cell dysfunction was increased with genetic PD1 deficiency, resulting in terminal exhaustion and decreased stability of the CD8 + T cell population. These findings have important implications for different therapeutic clinical ap proaches because longterm or "maintenance" PD1 pathway blockade and genetically engineered T cells with altered PD1 are being considered in human cancer patients. There are several key questions that should be addressed to determine the most effective strategies for use of PD1 pathway inhibi tors in humans. First, in the experimental model used here, PD1 signaling is absent for CD8 + T cell priming as well as throughout chronic stimulation. It remains unclear whether PD1 deficiency has the same effect at different stages of T cell differentiation. Conditional deletion of PD1 signals should be used to resolve this issue in future studies. Second, the function of PD1 may vary depending on the strength of TCR stimulation. Here, we show that robust TCR signaling in PD1 KO P14 cells leads to increased cell death and loss of population durability. These observations are consistent with previous work demonstrating that stronger T cell stimulation leads to more severe exhaustion and clonal deletion (Wherry et al., 2003a) . In LCMV clone 13 infection, CD8 + T cells re sponding to the NP396 epitope rapidly progress through ex haustion and are physically deleted because of overstimulation, whereas CD8 + T cells specific for GP33 and GP276 persist but become exhausted (Wherry et al., 2003a) . The prevailing hypothesis is that the strength of TCR stimulation determines deletion versus exhaustion. Removal of PD1 increases the strength of TCR signals received by GP33specific P14 cells in the current study, which accelerates their exhaustion and leads to eventual deletion. However, deletion of PD1 KO P14 cells is much slower than observed for the NP396 specific population in WT mice. This difference could indicate that the strength of NP396 stimulation is still greater than GP33 stimulation, even in the absence of PD1-mediated in hibition. Alternatively, there could be other features of stimu lation that are important in determining deletion versus exhaustion of different epitopespecific T cell populations (e.g., different APCs, direct versus crosspresentation, T cell pre cursor frequency, etc.). It will be interesting to determine the relative impact of PD1 deficiency on CD8 + T cells of other specificities and to begin to dissect these issues. We would predict that loss of PD1 in T cells exposed to stronger stim ulation would result in accelerated and/or more severe ex haustion, as well as more rapid deletion. Third, it is unclear whether genetic absence of PD1 is equivalent to antibody mediated blockade. Given the broad expression of PD1 and PD1 ligands (Keir et al., 2008) , blockade of this pathway may impact a variety of immune and nonimmune cell types. Fi nally, the impact of prolonged inhibition of the PD1 path way may be considerably different in the presence versus absence of highlevel antigen stimulation. In the current setting of chronic LCMV infection, where the antigen stimulation BrdU treatment and detection. Animals were treated with 2 mg BrdU (SigmaAldrich) i.p. daily for 1-5 d before tissue harvest and analysis. BrdU incorporation was assessed by the BrdU Flow kit (BD) per the manufac turer's instructions.
In vitro stimulation. Naive WT and PD1 KO P14 cells were isolated from spleens by CD8 negative selection (Stem Cell Technologies) and cul tured in RPMI1640 medium in the presence of 100 U/ml recombinant human IL2 (R&D Systems). Naive P14 cells were stimulated for 4 d by coculturing with GP33 peptide-pulsed naive splenocytes.
Cytotoxicity assay. Splenocytes from WT mice were labeled with two different concentrations (50 nM = "dim" or 1 µM = "bright") of CTV. CTV dim target splenocytes were incubated with GP33 peptide, whereas CTV bright splenocytes were incubated with SIINFEKL peptide for 1 h at 37°C. 2 × 10 3 GP33pulsed target cells were mixed with 2 × 10 3 SIINFEKL pulsed control cells. WT and PD1 KO P14 cells were isolated from day 29 LCMV clone 13-infected spleens by cell sorting on a FACSAria II. 8 × 10 3 WT or PD1 KO P14 cells were added to wells containing target and control cells in triplicate. Unlabeled, WT CD45.1 + splenocytes were used to nor malize cell concentrations in each well. After 16 h at 37°C, target cells were assessed by flow cytometry. Percentspecific lysis was calculated as 100 × [1  (% target cells remaining/% control cells remaining)].
Statistical analysis. Student's t tests (paired and unpaired) were performed using Prism software (GraphPad Software).
